Clinical

Dataset Information

0

Evaluation of the immune-profiling for patients participating in Phase Ib/II Study of BBI608 in Combination with Pembrolizumab and the relationship between the immune-profiling and efficacy using paired biopsies and peripheral blood.

ABSTRACT: Primary outcome(s): Evaluation of the immune-profiling.

DISEASE(S): Metastatic Colorectal Cancer

PROVIDER: 2639746 | ecrin-mdr-crc |

REPOSITORIES: ECRIN MDR

Json Xml

Similar Datasets

Unknown Single cell immune profiling of human cervix biopsies
2021-04-24 | GSE173231 | GEO
Genomics Single cell immune profiling of human cervix biopsies
| PRJNA724733 | ENA
Unknown Phase Ib Study of Lenvatinib Plus Pembrolizumab in Patients With Unresectable Hepatocellular Carcinoma.
| S-EPMC7479760 | biostudies-literature
Unknown In Situ Immune Profiling of Heart Transplant Biopsies Improves Diagnostic Accuracy and Rejection Risk Stratification.
| S-EPMC7188920 | biostudies-literature
Transcriptomics Expression of Pembrolizumab-treated tumors
2023-10-01 | E-MTAB-8288 | biostudies-arrayexpress
Unknown Pembrolizumab in Patients With Advanced Triple-Negative Breast Cancer: Phase Ib KEYNOTE-012 Study.
| S-EPMC6816000 | biostudies-literature
Unknown Phase Ib/II Study of Pembrolizumab and Pegylated-Interferon Alfa-2b in Advanced Melanoma.
| S-EPMC6286160 | biostudies-literature
Unknown A phase Ib study of pembrolizumab plus chemotherapy in patients with advanced cancer (PembroPlus).
| S-EPMC5520208 | biostudies-literature
Clinical A Phase Ib/II Study of BBI608 in Combination with Pembrolizumab in Patients with Metastatic Colorectal Cancer
| 2638404 | ecrin-mdr-crc
Unknown Immune-enrichment of non-small cell lung cancer baseline biopsies for multiplex profiling define prognostic immune checkpoint combinations for patient stratification.
| S-EPMC6437930 | biostudies-literature